A Comparision of Tablet Nifedipine with Tablet Methyldopa in Controlling Mild to Moderate Pregnancy induced Hypertension (PIH)

被引:0
作者
Fakhir, Nazia [1 ]
Masood, Humaira [2 ]
Khanum, Wajiha [2 ]
Faisal, Jaweria [3 ]
Kanwal, Sadia [4 ]
Afridi, Nighat [5 ]
机构
[1] Benazir Bhutto Hosp, Obstet & Gynaecol, Rawalpindi, Pakistan
[2] Benazir Bhutto Hosp, Rawalpindi, Pakistan
[3] Isra Univ, Obstet & Gynaecol, Al Nafees Med Coll & Hosp, Islamabad, Pakistan
[4] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad, Pakistan
[5] Combined Mil Hosp, Dept Obstet & Gynaecol, Peshawar, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2020年 / 14卷 / 03期
关键词
Hypertension; Pregnancy; Methyldopa; Nifedipine;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare the efficacy of tablet nifedipine and tablet methyldopa in controlling mild to moderate pregnancy induced hypertension. Study Design: Randomized control trial. Place and Duration of Study: Department of Obstetrics & Gynaecology Benazir Bhutto Hospital Rawalpindi Pakistan from 01 May 2019 to October 2019. Methodology: Two hundred and thirty six patients with mild to moderate pregnancy induced hypertension were selected and randomized based on lottery method to either group A or group B. Group A received tablet Methyldopa 250mg TDS while Group B received tablet Nifedipine 10mg bd. BP was checked 4 hourly for 24 hours and then decided which medicine control the BP best. Results: The mean age of the study group was 30.39 +/- 5.087 years. There was no statistically significant difference in the age of both groups. The majority of the patient in our study was multigravida, in the last trimester of pregnancy and had a history of hypertension in previous pregnancy. There were eight treatment failure in Methyldopa group while two treatment failure in Nifedipine group. Thus Methyldopa and Nifedipine had comparable efficacy in controlling blood pressure. Conclusion: Nifedipine is equally effective as compare to Methyldopa in controlling mild to moderate hypertension in pregnancy and can be considered as effective alternative to Methyldopa.
引用
收藏
页码:1469 / 1471
页数:3
相关论文
共 15 条
  • [1] Begum F, 2008, BANG J OBSTET GYNECO, V23, P65
  • [2] Bharathi KN, 2010, J CLIN DIAGN RES, V4, P2406
  • [3] Preeclampsia and Risk of Developing Subsequent Diabetes
    Carr, D. B.
    Newton, K. M.
    Utzschneider, K. M.
    Tong, J.
    Gerchman, F.
    Kahn, S. E.
    Easterling, T. R.
    Heckbert, S. R.
    [J]. HYPERTENSION IN PREGNANCY, 2009, 28 (04) : 435 - 447
  • [4] Cifkova R, 2009, Cas Lek Cesk, V148, P65
  • [5] Ghanem F, 2008, USE ANTIHYPERTENSIVE
  • [6] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy
    Gifford, RW
    August, PA
    Cunningham, G
    Green, LA
    Lindheimer, MD
    McNellis, D
    Roberts, JM
    Sibai, BM
    Taler, SJ
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (01) : S1 - S22
  • [7] Antihypertensive Therapy and Central Hemodynamics in Women With Hypertensive Disorders in Pregnancy
    Khalil, Asma
    Jauniaux, Eric
    Harrington, Kevin
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 113 (03) : 646 - 654
  • [8] Pharmacotherapeutic options for the treatment of preeclampsia
    McCoy, Stacey
    Baldwin, Kathleen
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (04) : 337 - 344
  • [9] Ozsvar Zsofia, 2010, Orvosi Hetilap, V151, P457, DOI 10.1556/OH.2010.28736
  • [10] Parveen N, 2009, J LIAQUAT UNIV MED H, V8, P242